Open original FDA record ↗Recall record
- FDA identifier
- Z-0890-2013
- Company in FDA record
- Oculus Innovative Sciences Inc
- FDA classification date
- Feb 26, 2013
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Out of specification result - stability test failure of free available chlorine (FAC) which functions as a preservative for the hydrogel. The 13 month test result obtained was 4 ppm FAC and the stability specification is >10 ppm FAC.
Source facts
- Action
- Oculus sent an Urgent Medical Device Recall letter dated February 12, 2013, to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to immediately discontinue distribution and segregate the affected product. Immediately remove the affected lots of Recall product from the inventory of sales representative, sub contracted distribution and or fulfillment centers. Segregate the affected product in a secure location for return or destruction. If the product was further distributed customers were instructed to notify healthcare professionals of this recall. Customers were also instructed to completed and return the Business Reply Card and fax to 1-415-462-5163. Once the firm receives the affected product the customer would be contacted by an Oculus Representative and provided a Returns Goods Authorization (RGA) number. For questions customers were instructed to call 1-707-559-2445. For questions regarding this recall 707-559-7191, ext 14.
- Initiated
- 2013-02-12
- Root cause
- Incorrect or no expiration date
- Terminated
- 2013-11-25
- Distribution
- Nationwide Distribution - One distributor in PA
- Recall number
- Z-0890-2013
- Recall status
- Terminated
- CDRH record ID
- 115812
- FDA classified
- 2013-02-26
- Recall event number
- 64316